Skip to main content
Equibles

CRDL · Cardiol Therapeutics Inc.

Track CRDL — free

Use CRDL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRDL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.33 -0.08 (-5.67%)
Rebalance outlook locked
Market Cap
$205.37M
Shares
121.51M
Volume · Oct 5 2.96M Avg daily vol (3M) 1.29M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.41 Open$1.60 Day$1.40–1.64 52W close$0.93–2.29 Avg vol 30d1.5M Short int3.3M · 2.7% float · 2.2d Short vol27% DataJan 2020–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
-49,091.9%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+21.4%
Year over year · more shares
Price change (1Y)
+34.3%
Trailing year
Short interest
2.7%
Latest settlement · 2.2 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +10%
above
Price vs 50-day avg −19%
below
RSI (14) 27
oversold
MACD trend Negative
52-week position 36%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Neutral
1-month return −35%
trailing
6-month return +4%
trailing
YTD return +48%
this year
Relative strength −9%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow Accumulating
+13% holders QoQ · +11 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.73% of float · ▲ +13.2% MoM · 2.2 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
53 holders — near 3-yr high, broad support
Squeeze score 56
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 63%
annualized · 1-yr
Max drawdown −39%
past year
ATR 8.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+10% Bullish
Price vs 50-day avg
−19% Bearish
RSI (14)
27 Neutral
MACD trend
Negative Bearish
52-week position
36% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow Accumulating
+13% holders QoQ · +11 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.73% of float · ▲ +13.2% MoM · 2.2 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
53 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $1 · 36% Range high $2
vs 200-day avg +10% vs 50-day avg -19%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CRDL
Cardiol Therapeutics Inc.
this stock
$205.37M +47.8% — — 2.7%
TAK
Takeda Pharmaceutical Co Ltd
 $60.23B +14.6% — — 0.1%
GALDY
Galderma Group AG/ADR
 $46.00B -6.5% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $45.67B +26.7% +4.3% 64.3 2.7%
HLN
Haleon plc
 $40.72B -13.0% — — 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
53
% held
24.3%
Net QoQ
+1.6M sh
Top holder
MMCAP International Inc.…
Held Float
View
Held by Funds
Fund positions
4
View
Short & Settlement
Short Interest Rising
Shares short
3.3M
Days to cover
2.2d
Change
+385.4K sh
View
Short Volume
Short vol %
27%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
18.4K
Value
$36.7K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
41.9%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 23, 2026
This year
31
View
Exempt Offerings
Offering
$8.5M
Filed
Nov 4, 2025
View
Earnings & Events
Webcasts
Last webcast
Sep 14, 2026
View

Performance

5D 20D 120D MTD YTD
CRDL -17.5% -34.7% +3.7% -15.1% +47.8%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -17.3% -34.3% -8.5% -16.0% +34.9%
Key facts CIK 1702123 CUSIP 14161Y200 13F (30d) 1 filings 1 filers Visit website Investor relations